EVO News
Evotec Announces Chief Scientific Officer Transition
Evotec Announces Chief Scientific Officer Transition Evotec Announces Chief Scientific Officer TransitionPR NewswireHAMBURG, Germany, Sept. 29, 2026 Dr. Cord Dohrmann to step down as of September 30, 2026Search ongoing for a successorHAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE...
PR Newswire
Evotec Announces Chief Scientific Officer Transition
Evotec Announces Chief Scientific Officer Transition Evotec Announces Chief Scientific Officer TransitionPR NewswireHAMBURG, Germany, Sept. 29, 2026 Dr. Cord Dohrmann to step down as of September 30, 2026Search ongoing for a successorHAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE...
PR Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million.
Evotec (NASDAQ:EVO) stock rose 8.44% toread more...
Benzinga
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies PR Newswire SEATTLE and HAMBURG, Germany, Sept. 9, 2026...
PR Newswire
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors PR Newswire HAMBURG, Germany and HALLBERGMOOS...
PR Newswire
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases PR Newswire HAMBURG, Germany, Aug. 6, 2026 Collaboration combines Odyssey's disease...
PR Newswire
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has selected Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), a global life science company specializing in drug...
Business Wire
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its...
Business Wire
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook PR Newswire HAMBURG, Germany, July 13, 2026 Disclosure of an inside...
PR Newswire
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics PR Newswire SEATTLE and HAMBURG, Germany, June 30, 2026 Expands Just Evotec Biologics...
PR Newswire
Evotec Reports Results of the Annual General Meeting 2026
Evotec Reports Results of the Annual General Meeting 2026 Evotec Reports Results of the Annual General Meeting 2026 PR Newswire HAMBURG, Germany, June 11, 2026 11.06.2026 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement. All agenda items adoptedDieter Weinand...
PR Newswire